The Technical AnalystExchange: ASX Industry: Health Care Equipment & Services
Monash IVF Group Ltd Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.51% $1.482
America/New_York / 3 mai 2024 @ 01:57
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 577.44 mill |
| EPS: | 0.0600 |
| P/E: | 24.70 |
| Earnings Date: | Feb 22, 2024 |
| SharesOutstanding: | 389.64 mill |
| Avg Daily Volume: | 1.002 mill |
| RATING 2024-05-02 |
|---|
| A+ |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Buy | |
| P/E: | Neutral | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/21 | 4/21 | 2/22 | 4/22 | 2/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 19.64x |
| Company: PE 24.70 | sector: PE 1.258 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.46x |
| Company: PE 24.70 | industry: PE 54.21 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$0.923 (-37.71%) $-0.559 |
| Date: 2024-05-02 |
| Expected Trading Range (DAY) |
|---|
|
$ 1.444 - 1.516 ( +/- 2.43%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $1.482 (1.51% ) |
| Volume | 1.363 mill |
| Avg. Vol. | 1.002 mill |
| % of Avg. Vol | 135.92 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MVF.AX
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
MVF.AX
Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. The company was incorporated in 2014 and is based in Richmond, Australia.